GPIBD17
MCID: GLY107
MIFTS: 18

Glycosylphosphatidylinositol Biosynthesis Defect 17 (GPIBD17)

Categories: Bone diseases, Genetic diseases, Mental diseases, Neuronal diseases

Aliases & Classifications for Glycosylphosphatidylinositol Biosynthesis Defect 17

MalaCards integrated aliases for Glycosylphosphatidylinositol Biosynthesis Defect 17:

Name: Glycosylphosphatidylinositol Biosynthesis Defect 17 58 76 6
Gpibd17 58 76

Characteristics:

OMIM:

58
Inheritance:
autosomal recessive

Miscellaneous:
variable severity
onset in infancy or early childhood
three patients from 2 unrelated consanguineous families have been reported (last curated june 2018)


HPO:

33
glycosylphosphatidylinositol biosynthesis defect 17:
Onset and clinical course variable expressivity


Classifications:



Summaries for Glycosylphosphatidylinositol Biosynthesis Defect 17

OMIM : 58 Glycosylphosphatidylinositol biosynthesis defect-17 is an autosomal recessive disorder characterized by variable neurologic deficits that become apparent in infancy or early childhood. Patients may present with early-onset febrile or afebrile seizures that tend to be mild or controllable. Other features may include learning disabilities, autism, behavioral abnormalities, hypotonia, and motor deficits. The phenotype is relatively mild compared to that of other GPIBDs (summary by Nguyen et al., 2018). For a discussion of genetic heterogeneity of GPI biosynthesis defects, see GPIBD1 (610293). (618010)

MalaCards based summary : Glycosylphosphatidylinositol Biosynthesis Defect 17, is also known as gpibd17. An important gene associated with Glycosylphosphatidylinositol Biosynthesis Defect 17 is PIGH (Phosphatidylinositol Glycan Anchor Biosynthesis Class H). Related phenotypes are global developmental delay and hypertriglyceridemia

UniProtKB/Swiss-Prot : 76 Glycosylphosphatidylinositol biosynthesis defect 17: An autosomal recessive disorder characterized by variable neurologic deficits that become apparent in infancy or early childhood. Clinical features include learning disabilities, mild-to-moderate developmental delay, seizures of variable severity, aggressive or over-friendly behavior, and autistic features.

Related Diseases for Glycosylphosphatidylinositol Biosynthesis Defect 17

Symptoms & Phenotypes for Glycosylphosphatidylinositol Biosynthesis Defect 17

Human phenotypes related to Glycosylphosphatidylinositol Biosynthesis Defect 17:

33
# Description HPO Frequency HPO Source Accession
1 global developmental delay 33 very rare (1%) HP:0001263
2 hypertriglyceridemia 33 very rare (1%) HP:0002155
3 dysplastic corpus callosum 33 very rare (1%) HP:0006989
4 seizures 33 HP:0001250
5 aggressive behavior 33 HP:0000718

Symptoms via clinical synopsis from OMIM:

58
Neurologic Behavioral Psychiatric Manifestations:
aggressive behavior
autistic features
over-friendly behavior

Skeletal Hands:
fifth finger clinodactyly

Skeletal Feet:
fifth toe clinodactyly

Head And Neck Head:
small head circumference

Laboratory Abnormalities:
normal alkaline phosphatase
decreased gpi-anchored proteins on granulocyte surface
increased triglycerides (in some patients)

Muscle Soft Tissue:
hypotonia

Head And Neck Mouth:
high-arched palate

Neurologic Central Nervous System:
learning disabilities
normal early development
delayed development, mild to moderate (in some patients)
limited speech (in some patients)
poor motor function (in some patients)
more
Growth Other:
poor overall growth

Head And Neck Ears:
abnormal ears

Clinical features from OMIM:

618010

Drugs & Therapeutics for Glycosylphosphatidylinositol Biosynthesis Defect 17

Search Clinical Trials , NIH Clinical Center for Glycosylphosphatidylinositol Biosynthesis Defect 17

Genetic Tests for Glycosylphosphatidylinositol Biosynthesis Defect 17

Anatomical Context for Glycosylphosphatidylinositol Biosynthesis Defect 17

Publications for Glycosylphosphatidylinositol Biosynthesis Defect 17

Variations for Glycosylphosphatidylinositol Biosynthesis Defect 17

UniProtKB/Swiss-Prot genetic disease variations for Glycosylphosphatidylinositol Biosynthesis Defect 17:

76
# Symbol AA change Variation ID SNP ID
1 PIGH p.Ser103Pro VAR_080993 rs776038451

ClinVar genetic disease variations for Glycosylphosphatidylinositol Biosynthesis Defect 17:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 PIGH NM_004569.4(PIGH): c.1A> T (p.Met1Leu) single nucleotide variant Pathogenic rs761543313 GRCh37 Chromosome 14, 68066920: 68066920
2 PIGH NM_004569.4(PIGH): c.1A> T (p.Met1Leu) single nucleotide variant Pathogenic rs761543313 GRCh38 Chromosome 14, 67600203: 67600203
3 PIGH NM_004569.4(PIGH): c.307T> C (p.Ser103Pro) single nucleotide variant Pathogenic rs776038451 GRCh37 Chromosome 14, 68060543: 68060543
4 PIGH NM_004569.4(PIGH): c.307T> C (p.Ser103Pro) single nucleotide variant Pathogenic rs776038451 GRCh38 Chromosome 14, 67593826: 67593826

Expression for Glycosylphosphatidylinositol Biosynthesis Defect 17

Search GEO for disease gene expression data for Glycosylphosphatidylinositol Biosynthesis Defect 17.

Pathways for Glycosylphosphatidylinositol Biosynthesis Defect 17

GO Terms for Glycosylphosphatidylinositol Biosynthesis Defect 17

Molecular functions related to Glycosylphosphatidylinositol Biosynthesis Defect 17 according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 catalytic activity GO:0003824 8.62 GPHN PIGH

Sources for Glycosylphosphatidylinositol Biosynthesis Defect 17

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....